Invesco
APYX icon

Invesco’s Apyx Medical APYX Stock Holding History

Invesco’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,861
Closed -$71K – 4040
2022
Q1 		$71K Buy
10,861
+93
+0.9% +$916 ﹤0.01% 3897
2021
Q4 		$138K Sell
10,768
-4,406
-29% -$61.6K ﹤0.01% 3852
2021
Q3 		$210K Buy
15,174
+3,773
+33% +$39.7K ﹤0.01% 3779
2021
Q2 		$117K Buy
+11,401
New +$113K ﹤0.01% 3875
2019
Q2 		– Sell
-169,015
Closed -$1.07M – 3717
2019
Q1 		$1.07M Buy
169,015
+154,903
+1,098% +$1.2M ﹤0.01% 2987
2018
Q4 		$91K Buy
+14,112
New +$85.5K ﹤0.01% 3660

Other funds holding APYX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
IP
Invenire Partners Ridgefield, Connecticut $65.3M AUM 18.1% 1-Year Est. Return